PIP4K2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.841600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.478800E-01
Normal-vs-Stage2
3.931600E-01
Normal-vs-Stage3
3.371400E-01
Normal-vs-Stage4
3.957200E-01
Stage1-vs-Stage2
3.345000E-01
Stage1-vs-Stage3
7.855800E-01
Stage1-vs-Stage4
2.762400E-01
Stage2-vs-Stage3
3.256800E-01
Stage2-vs-Stage4
9.805200E-01
Stage3-vs-Stage4
1.395610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.822600E-01
Normal-vs-AfricanAmerican
4.616800E-01
Normal-vs-Asian
3.373800E-01
Caucasian-vs-AfricanAmerican
1.695420E-01
Caucasian-vs-Asian
1.722580E-01
AfricanAmerican-vs-Asian
4.183700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.769000E-01
Normal-vs-Female
3.932000E-01
Male-vs-Female
3.636200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.036400E-01
Normal-vs-Age(41-60Yrs)
4.118800E-01
Normal-vs-Age(61-80Yrs)
3.732000E-01
Normal-vs-Age(81-100Yrs)
3.675200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.916800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.810600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.948400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.854000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.021200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.595400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.688800E-01
Normal-vs-Daily Drinker
3.590000E-01
Normal-vs-Weekly Drinker
3.736600E-01
Normal-vs-Occasional Drinker
3.595800E-01
Normal-vs-Social Drinker
3.732600E-01
Non Drinker-vs-Daily Drinker
7.419200E-01
Non Drinker-vs-Weekly Drinker
8.967400E-01
Non Drinker-vs-Occasional Drinker
7.740600E-01
Non Drinker-vs-Social Drinker
9.242800E-01
Daily Drinker-vs-Weekly Drinker
6.130600E-01
Daily Drinker-vs-Occasional Drinker
9.902200E-01
Daily Drinker-vs-Social Drinker
6.835400E-01
Weekly Drinker-vs-Occasional Drinker
6.567200E-01
Weekly Drinker-vs-Social Drinker
9.784600E-01
Occasional Drinker-vs-Social Drinker
7.205000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.470800E-01
Normal-vs-Grade 2
9.134600E-01
Normal-vs-Grade 3
9.596200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.034800E-01
Grade 1-vs-Grade 3
9.205400E-01
Grade 1-vs-Grade 4
9.470800E-01
Grade 2-vs-Grade 3
1.287840E-02
Grade 2-vs-Grade 4
9.134600E-01
Grade 3-vs-Grade 4
9.596200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.950400E-01
Normal-vs-NonDiabetic
3.655000E-01
Diabetic-vs-NonDiabetic
2.047400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.539000E-01
Normal-vs-NoPancreatitis
3.775600E-01
Pancreatitis-vs-NoPancreatitis
2.203200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.764600E-01
Normal-vs-N1
3.915200E-01
N0-vs-N1
4.327200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.024000E-01
Normal-vs-TP53-NonMutant
3.361800E-01
TP53-Mutant-vs-TP53-NonMutant
1.410820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
